Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2024 - 2025)

Indivior Pharmaceuticals (INDV) recorded quarterly Exchange Rate Effect of -$2.0 million in Q3 2025, down 300.0% quarter-over-quarter from $1.0 million in Q2 2025, and down 100.0% on a YoY basis from -$inf billion in Q3 2024.

Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2024 - 2025) Analysis & Trends

Indivior Pharmaceuticals' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at -$2.0 million for Q3 2025.

  • In Q3 2025, Exchange Rate Effect fell 100.0% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$1.0 million (changed N/A YoY), while the FY2025 annual figure was -$1.0 million, changed N/A from the prior year.
  • Exchange Rate Effect was -$2.0 million for Q3 2025 at Indivior Pharmaceuticals, down from $1.0 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.0 million in Q4 2024 to a low of -$2.0 million in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FX Effect (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -17.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 17.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -5.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -22,000.00
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -2.38 Mn
10 Indivior Pharmaceuticals - - 277.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -2.00 Mn
Sep 30, 2025 -2.00 Mn
Jun 30, 2025 1.00 Mn
Jun 30, 2025 1.00 Mn
Dec 31, 2024 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 -1.00 Mn
Sep 30, 2024 -1.00 Mn